ADIA and GIC Invest in Pharmaceutical Product Development

Pharmaceutical Product Development, LLC (PPD) has been recapitalized by permitting the Abu Dhabi Investment Authority (ADIA) and Singapore’s GIC Private Limited acquire minority ownership interests. [ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]

Contact the writer or creator of this article or page.
Questions or comments: support(at)swfinstitute(dot)org
Follow on Twitter at @swfinstitute and @sovereignfunds
Learn, Attend and Network: Institutional Investor Events and Summits
Go Back: HOME: Sovereign Wealth Fund Institute

institutional investor investment mandates